Literature DB >> 20486193

Candida dubliniensis screening using the germ tube test in clinical yeast isolates and prevalence of C. dubliniensis in Korea.

Tae-Hyoung Kim1, Bo-Rae G Park, Hye Ryoun Kim, Mi-Kyung Lee.   

Abstract

The aim of this study was to screen for C. dubliniensis using the germ tube test with human pooled serum (HPS) in clinical isolates and investigate the prevalence of C. dubliniensis in Korea. Among 1,854 yeast strains isolated, 1,404 strains of C. albicans (on the basis of positive results of the germ tube test) and 192 germ tube-negative yeast strains were examined. All 1,596 clinical isolates were examined using the germ tube test with HPS, the differential temperature, and NaCl tolerance test. Only 81 isolates that did not grow at 45 degrees C nor on Sabouraud 6.5% NaCl broth were selected and tested using the VITEK 2 ID-YST system and the multiplex-PCR assay for the study. The two strains, C. dubliniensis ATCC MYA-646 and KCTC 17427 failed to produce germ tubes in HPS but produced them in fresh rabbit serum (FRS) and fetal bovine serum (FBS). No C. dubliniensis was found in this study population. The results of this study suggest that the germ tube test with HPS in combination with FRS or FBS can be used for discriminating between C. albicans and C. dubliniensis strains and that the prevalence of C. dubliniensis appears to be extremely low in Korea. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486193      PMCID: PMC6647691          DOI: 10.1002/jcla.20373

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis.

Authors:  P Staib; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

2.  Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Authors:  A Borst; B Theelen; E Reinders; T Boekhout; A C Fluit; P H M Savelkoul
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.

Authors:  W R Kirkpatrick; S G Revankar; R K Mcatee; J L Lopez-Ribot; A W Fothergill; D I McCarthy; S E Sanche; R A Cantu; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Prevalence of Candida dubliniensis isolates in a yeast stock collection.

Authors:  F C Odds; L Van Nuffel; G Dams
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.

Authors:  D Sullivan; K Haynes; J Bille; P Boerlin; L Rodero; S Lloyd; M Henman; D Coleman
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Candida carriage and Candida dubliniensis in oropharyngeal samples of type-1 diabetes mellitus patients.

Authors:  A Tekeli; I Dolapci; R Emral; S Cesur
Journal:  Mycoses       Date:  2004-08       Impact factor: 4.377

8.  Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening.

Authors:  Sydney Hartz Alves; Eveline Pipolo Milan; Priscilla de Laet Sant'Ana; Loiva O Oliveira; Janio M Santurio; Arnaldo Lopes Colombo
Journal:  Diagn Microbiol Infect Dis       Date:  2002-05       Impact factor: 2.803

9.  Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.

Authors:  E Pinjon; D Sullivan; I Salkin; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 10.  Candida dubliniensis, a new fungal pathogen.

Authors:  J Gutiérrez; P Morales; M A González; G Quindós
Journal:  J Basic Microbiol       Date:  2002       Impact factor: 2.281

View more
  4 in total

1.  First isolation of Candida dubliniensis from oral cavities of dermatological patients in Nanjing, China.

Authors:  Yi P Ge; Guo X He; Tong Lin; Gui X Lu; Yong N Shen; Wei D Liu
Journal:  Mycopathologia       Date:  2011-07-17       Impact factor: 2.574

2.  The usefulness of DNA sequencing after extraction by Whatman FTA filter matrix technology and phenotypic tests for differentiation of Candida albicans and Candida dubliniensis.

Authors:  Nuri Kiraz; Yasemin Oz; Huseyin Aslan; Hamza Muslumanoglu
Journal:  Mycopathologia       Date:  2014-01-17       Impact factor: 2.574

3.  Lab-Based Retrospective 10-Year Analysis Shows Seasonal Variation of Vaginal Candida Infection Rates in Belgium.

Authors:  Gilbert G G Donders; Kateryna Ruban; Francesca Donders; Reinhilde Reybrouck
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

4.  The first Korean case of candidemia due to Candida dubliniensis.

Authors:  Nae Yu; Hye Ryoun Kim; Mi-Kyung Lee
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.